Document Detail

Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency.
MedLine Citation:
PMID:  9234038     Owner:  NLM     Status:  MEDLINE    
Counselors (N = 12) in 1 of 2 substance abuse treatment facilities were asked to identify which of their patients (N = 97) had general neurocognitive impairment. Counselors were required to base their judgements on information collected from patients during psychosocial history gathering, clinical interviews, physical examinations, brief cognitive screening tests, and substance abuse severity evaluations, but not on neuropsychological test results. All patients were subsequently administered a neuropsychological test battery. Diagnostic agreement between counselors' impressions of patients' cognitive status and patients' actual neuropsychological test performance was poor. Subsequent analyses revealed counselors' impressions about patients' neuropsychological functioning were based on information that did not reliably discriminate between cognitively impaired and intact patients (e.g., years of education and self-reported symptoms of cognitive dysfunction).
W Fals-Stewart
Related Documents :
19158418 - Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive d...
18000948 - Do family caregivers perceive more difficulty when they look after patients with early ...
17195278 - Patients with lewy body dementia use more resources than those with alzheimer's disease.
18261878 - Patients dying with dementia: experience at the end of life and impact of hospice care.
11758628 - A measurement of the efficacy of anticoagulation monitoring in a general practice based...
18498958 - Erectile dysfunction as a predictor of cardiovascular events and death in diabetic pati...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Experimental and clinical psychopharmacology     Volume:  5     ISSN:  1064-1297     ISO Abbreviation:  Exp Clin Psychopharmacol     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-09-12     Completed Date:  1997-09-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9419066     Medline TA:  Exp Clin Psychopharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  39-50     Citation Subset:  IM    
Department of Psychiatry, Harvard Medical School, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cognition / drug effects*
Neuropsychological Tests
Psychiatric Status Rating Scales
Substance Abuse Detection*
Substance-Related Disorders / psychology*,  rehabilitation
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute participant-rated and behavioral effects of alprazolam and buspirone, alone and in combination...
Next Document:  Changes in cigarette smoking not observed following repeated cocaine self-administration.